Seasonal affective disorder or SAD is a recurrent major depressive disorder with a seasonal pattern usually beginning in fall and continuing into winter months.

Market Analysis and Insights: Global Seasonal Affective Disorder Drugs Market
The global Seasonal Affective Disorder Drugs market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

Global Seasonal Affective Disorder Drugs Scope and Market Size
Seasonal Affective Disorder Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Affective Disorder Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
SSRIs
SNRIs
NDRIs
TCAs
MOAIs

Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

By Company
Pfizer
GlaxoSmithKline
Bristol-Myers Squibb
Otsuka Pharmaceutical
Mylan
Merck

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia